BNP PARIBAS FINANCIAL MARKETS - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 90 filers reported holding PIERIS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$98,120,000
-89.6%
32,383
-87.1%
0.00%
-100.0%
Q4 2021$945,828,000
+21578.4%
250,219
+29546.8%
0.00%
Q3 2021$4,363,000
+4.8%
844
-22.4%
0.00%
Q2 2021$4,163,000
-78.2%
1,087
-85.4%
0.00%
Q1 2021$19,080,000
-39.6%
7,424
-41.2%
0.00%
Q4 2020$31,588,000
+9.9%
12,635
-9.0%
0.00%
Q3 2020$28,744,000
+393.5%
13,886
+639.0%
0.00%
Q2 2020$5,825,000
-83.7%
1,879
-88.0%
0.00%
Q1 2020$35,689,000
+40.4%
15,653
+122.9%
0.00%
Q4 2019$25,427,000
-10.2%
7,024
-15.4%
0.00%
Q3 2019$28,306,000
-5.0%
8,301
+31.0%
0.00%
Q2 2019$29,793,000
-17.7%
6,339
-41.3%
0.00%
Q1 2019$36,197,000
+293.7%
10,805
+558.0%
0.00%
Q3 2018$9,195,000
+8.7%
1,642
-1.6%
0.00%
Q2 2018$8,457,000
-86.4%
1,668
-81.7%
0.00%
Q1 2018$62,185,000
+6.7%
9,118
+18.1%
0.00%
Q4 2017$58,301,000
+202.0%
7,722
+130.4%
0.00%
Q3 2017$19,308,000
+6.0%
3,352
-6.9%
0.00%
Q2 2017$18,216,0003,6000.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,136,319$3,443,0003.20%
Aquilo Capital Management, LLC 3,708,882$11,238,0001.65%
Soleus Capital Management, L.P. 4,134,868$12,529,0001.62%
GREAT POINT PARTNERS LLC 2,199,076$6,663,0001.61%
BVF INC/IL 5,328,239$16,145,0000.65%
Cutter & CO Brokerage, Inc. 406,229$1,231,0000.37%
WEALTH EFFECTS LLC 80,400$244,0000.11%
PLATINUM INVESTMENT MANAGEMENT LTD 1,028,322$3,116,0000.10%
Rhenman & Partners Asset Management AB 300,000$909,0000.09%
Woodline Partners LP 1,587,475$4,810,0000.08%
View complete list of PIERIS PHARMACEUTICALS INC shareholders